Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N R Cooper

Showing results (141-150 of 175) with videos related to

Pageof 18
Sort By:
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1971
[Reaction between the first component C1 of the complement system and immunoglobulins in relation to their class, subclass and physical condition]W Augener, H M Grey, N R Cooper, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1987
Molecular cloning of the cDNA encoding the Epstein-Barr virus/C3d receptor (complement receptor type 2) of human B lymphocytesM D Moore, N R Cooper, B F Tack, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1994
Substrate specificities of murine C1sR T Ogata, P J Low, B M Bradt, et al.
Cell|February 10, 1989
Identification of an epitope in the major envelope protein of Epstein-Barr virus that mediates viral binding to the B lymphocyte EBV receptor (CR2)G R Nemerow, R A Houghten, M D Moore, et al.
Medical Microbiology and Immunology|January 1, 1982
The role of antibody and complement in lysing virus-infected cellsJ G Sissons, R D Schreiber, N R Cooper, et al.
Virology|October 15, 1976
Inactivation of lysis of oncornaviruses by human serumR M Welsh, F C Jensen, N R Cooper, et al.
The Journal of Experimental Medicine|May 1, 1976
Mechanism of injury of virus-infected cells by antiviral antibody and complement: participation of IgG, F(ab')2, and the alternative complement pathwayL H Perrin, B S Joseph, N R Cooper, et al.
The Journal of Biological Chemistry|December 5, 1989
Hydrodynamic, electron microscopic, and ligand-binding analysis of the Epstein-Barr virus/C3dg receptor (CR2)M D Moore, R G DiScipio, N R Cooper, et al.
Immunochemistry|August 1, 1973
Consumption of human complement components by complexes of IgG with protein A of Staphylococcus aureusG Stålenheim, O Götze, N R Cooper, et al.
Journal of Virology|May 1, 1987
Identification of gp350 as the viral glycoprotein mediating attachment of Epstein-Barr virus (EBV) to the EBV/C3d receptor of B cells: sequence homology of gp350 and C3 complement fragment C3dG R Nemerow, C Mold, V K Schwend, et al.
Pageof 18

Showing results (141-150 of 175) with videos related to

Sort By:
Pageof 18
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1971
[Reaction between the first component C1 of the complement system and immunoglobulins in relation to their class, subclass and physical condition]W Augener, H M Grey, N R Cooper, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1987
Molecular cloning of the cDNA encoding the Epstein-Barr virus/C3d receptor (complement receptor type 2) of human B lymphocytesM D Moore, N R Cooper, B F Tack, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1994
Substrate specificities of murine C1sR T Ogata, P J Low, B M Bradt, et al.
Cell|February 10, 1989
Identification of an epitope in the major envelope protein of Epstein-Barr virus that mediates viral binding to the B lymphocyte EBV receptor (CR2)G R Nemerow, R A Houghten, M D Moore, et al.
Medical Microbiology and Immunology|January 1, 1982
The role of antibody and complement in lysing virus-infected cellsJ G Sissons, R D Schreiber, N R Cooper, et al.
Virology|October 15, 1976
Inactivation of lysis of oncornaviruses by human serumR M Welsh, F C Jensen, N R Cooper, et al.
The Journal of Experimental Medicine|May 1, 1976
Mechanism of injury of virus-infected cells by antiviral antibody and complement: participation of IgG, F(ab')2, and the alternative complement pathwayL H Perrin, B S Joseph, N R Cooper, et al.
The Journal of Biological Chemistry|December 5, 1989
Hydrodynamic, electron microscopic, and ligand-binding analysis of the Epstein-Barr virus/C3dg receptor (CR2)M D Moore, R G DiScipio, N R Cooper, et al.
Immunochemistry|August 1, 1973
Consumption of human complement components by complexes of IgG with protein A of Staphylococcus aureusG Stålenheim, O Götze, N R Cooper, et al.
Journal of Virology|May 1, 1987
Identification of gp350 as the viral glycoprotein mediating attachment of Epstein-Barr virus (EBV) to the EBV/C3d receptor of B cells: sequence homology of gp350 and C3 complement fragment C3dG R Nemerow, C Mold, V K Schwend, et al.
Pageof 18